Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib

Molecular Cancer Therapeutics
Junko MuraiYves Pommier

Abstract

Anti-PARP drugs were initially developed as catalytic inhibitors to block the repair of DNA single-strand breaks. We recently reported that several PARP inhibitors have an additional cytotoxic mechanism by trapping PARP-DNA complexes, and that both olaparib and niraparib act as PARP poisons at pharmacologic concentrations. Therefore, we have proposed that PARP inhibitors should be evaluated based both on catalytic PARP inhibition and PARP-DNA trapping. Here, we evaluated the novel PARP inhibitor, BMN 673, and compared its effects on PARP1 and PARP2 with two other clinical PARP inhibitors, olaparib and rucaparib, using biochemical and cellular assays in genetically modified chicken DT40 and human cancer cell lines. Although BMN 673, olaparib, and rucaparib are comparable at inhibiting PARP catalytic activity, BMN 673 is ∼100-fold more potent at trapping PARP-DNA complexes and more cytotoxic as single agent than olaparib, whereas olaparib and rucaparib show similar potencies in trapping PARP-DNA complexes. The high level of resistance of PARP1/2 knockout cells to BMN 673 demonstrates the selectivity of BMN 673 for PARP1/2. Moreover, we show that BMN 673 acts by stereospecific binding to PARP1 as its enantiomer, LT674, is several ...Continue Reading

References

Mar 26, 1992·Nature·M S Satoh, T Lindahl
Dec 3, 1999·Science·T Lindahl, R D Wood
Oct 26, 2005·Nature Cell Biology·Paul ChangTimothy J Mitchison
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Valérie SchreiberGilbert de Murcia
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Paul O Hassa, Michael O Hottiger
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan Ashworth
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ruth PlummerHilary Calvert
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shivaani KummarJames H Doroshow
Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
Oct 9, 2009·The New England Journal of Medicine·Jan H J Hoeijmakers
Jan 6, 2010·EMBO Molecular Medicine·Ana M Mendes-PereiraAlan Ashworth
Mar 5, 2010·Nature Reviews. Cancer·Michèle RouleauGuy G Poirier
Aug 12, 2010·Nature Reviews. Clinical Oncology·Susana BanerjeeAlan Ashworth
Oct 30, 2010·Nature Reviews. Drug Discovery·Shivanni KummarJames H Doroshow
Mar 16, 2011·Neoplasia : an International Journal for Oncology Research·Patrick J GroharLee J Helman
Jan 20, 2012·Nature·Christopher J Lord, Alan Ashworth
Feb 22, 2012·Nature Biotechnology·Elisabet WahlbergJohan Weigelt
Mar 6, 2012·Nature Structural & Molecular Biology·Arnab Ray ChaudhuriMassimo Lopes
Mar 10, 2012·BMC Medicine·Shivaani KummarJames H Doroshow
May 15, 2012·Science·Marie-France LangelierJohn M Pascal
Oct 30, 2012·Cancer Discovery·Janneke E JaspersSven Rottenberg
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier
Feb 2, 2013·Molecular Aspects of Medicine·Nicola J Curtin, Csaba Szabo
Feb 12, 2013·Nature Structural & Molecular Biology·Matteo BertiAlessandro Vindigni
Jul 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuqiao ShenAlan Ashworth

❮ Previous
Next ❯

Citations

Jul 16, 2014·Oral Oncology·Jana HeitmannTanguy Y Seiwert
Oct 30, 2014·The New England Journal of Medicine·Donal P McLornanGhulam J Mufti
Jan 26, 2016·Expert Opinion on Investigational Drugs·Stefano BoglioloBarbara Gardella
Oct 24, 2014·Annual Review of Medicine·Christopher J LordAlan Ashworth
Feb 6, 2016·Journal of the National Cancer Institute·Miguel A Villalona-CaleroCynthia Timmers
Jan 19, 2016·Nature Reviews. Cancer·Christopher J Lord, Alan Ashworth
Feb 21, 2016·Pharmacology & Therapeutics·Navnath S GavandeJohn J Turchi
Nov 4, 2015·Frontiers in Oncology·Tiffany K RicksRichard Pazdur
Jun 7, 2015·Biochemical and Biophysical Research Communications·Jing HuangMichael S Goldberg
Mar 17, 2015·Seminars in Radiation Oncology·Sue S YomDavid Raben
Sep 20, 2015·Bulletin du cancer·Valérie SchreiberFrançoise Dantzer
Apr 22, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Giuseppe CarlucciThomas Reiner
May 23, 2015·DNA Repair·Natalie R Gassman, Samuel H Wilson
Jun 17, 2016·Molecular & Cellular Oncology·Antonella SistiguIlio Vitale
Feb 25, 2015·Maturitas·Shifalika TangutooriSrinivas Sridhar
Jul 16, 2014·Biochimica Et Biophysica Acta·Barbara Lupo, Livio Trusolino
Dec 2, 2014·Cell Reports·Elizabeth StewartMichael A Dyer
Sep 10, 2014·Biochemical Pharmacology·Judith MichelsGuido Kroemer
Jan 8, 2015·Frontiers in Oncology·Wenrui DuanMiguel A Villalona-Calero
Dec 9, 2014·Biochimica Et Biophysica Acta·Isabella FaraoniFrancesco Lo-Coco
Jul 5, 2016·Cancer Cell International·Aurélia NollValérie Schreiber
Jun 30, 2016·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Hiroyuki YamasakiTsutomu Ohta
Oct 1, 2016·Nuclear Medicine and Biology·Redmond-Craig AndersonRobert H Mach
Oct 30, 2016·European Urology·Joaquin MateoJohann S de Bono
Aug 17, 2016·Endocrine-related Cancer·Kiranjit K DhillonChristopher J Lord
Oct 25, 2016·Radiation Research·David A GewirtzLawrence F Povirk
Nov 1, 2016·Science Translational Medicine·Yves PommierJohann de Bono
Nov 15, 2016·Expert Opinion on Therapeutic Patents·Zigao YuanYuyang Jiang
Dec 21, 2016·Future Medicinal Chemistry·Chandan KumarAnnamalai Arunachalam
Jan 25, 2017·Cancer Biotherapy & Radiopharmaceuticals·Samuel Sander EffronRobert H Mach
Jan 15, 2017·Seminars in Cell & Developmental Biology·Caleb DulaneyEddy S Yang
Mar 10, 2017·Expert Opinion on Investigational Drugs·Elaine ShumHaiying Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.